{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.3:c.91G>C",
          "cDNA Change": {
            "transcript": "NM_000345.3",
            "ref": "G",
            "alt": "C",
            "position": "91"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "P",
            "position": "30"
          },
          "Description in input context": "A30P mutation in alpha-synuclein"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005317"
  },
  "Experiment Method": [
    {
      "Assay Method": "Cell culture and overexpression",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "PC12/TetOn",
        "Description": "Inducible PC12/TetOn cells overexpressing wild-type or A30P mutant alpha-synuclein"
      },
      "Readout type": "Qualitative and Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.91G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function (increased aggregation and toxicity)",
          "Result Description": "A30P mutant showed increased aggregation and cytotoxicity compared to wild-type under stress conditions"
        },
        {
          "Variant": "NM_000345.3:c.91G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function (increased sensitivity to proteasome inhibition)",
          "Result Description": "A30P mutant exhibited heightened sensitivity to proteasome inhibition (MG132) compared to wild-type"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text"
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the text"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the text"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No specific threshold described in the text",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "No specific threshold described in the text",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Inhibition experiments",
      "Material used": {
        "Material Source": "Chemical inhibitor",
        "Material Name": "3-MA (autophagy inhibitor), MG132 (proteasome inhibitor)",
        "Description": "Use of 3-MA and MG132 to block macroautophagy and proteasome pathways, respectively"
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000345.3:c.91G>C",
          "Conclusion": "Abnormal",
          "Molecular Effect": "Gain-of-function (increased aggregation under autophagy inhibition)",
          "Result Description": "A30P mutant showed greater aggregation accumulation when macroautophagy was inhibited by 3-MA"
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly described in the text"
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly described in the text"
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly described in the text"
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly described in the text"
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "No specific threshold described in the text",
        "Source": "Custom"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "No specific threshold described in the text",
        "Source": "Custom"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}